CXCR2 signaling promotes secretory cancer‐associated fibroblasts in pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

CXCR2 signaling promotes secretory cancer‐associated fibroblasts in pancreatic ductal adenocarcinoma

Published:2020-05-26 Issue:7 Volume:34 Page:9405-9418
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Awaji Mohammad¹²,Saxena Sugandha¹,Wu Lingyun¹,Prajapati Dipakkumar R.¹,Purohit Abhilasha¹,Varney Michelle L.¹,Kumar Sushil³,Rachagani Satyanarayana³,Ly Quan P.⁴,Jain Maneesh³,Batra Surinder K.³,Singh Rakesh K.¹

Affiliation:

1. Department of Pathology and Microbiology University of Nebraska Medical Center Omaha NE USA

2. Department of Pathology and Laboratory Medicine King Fahad Specialist Hospital Dammam Saudi Arabia

3. Department of Biochemistry and Molecular Biology University of Nebraska Medical Center Omaha NE USA

4. Department of Surgical Oncology University of Nebraska Medical Center Omaha NE USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201902990R

Reference52 articles.

1. Cancer statistics, 2018

2. Pancreatic Cancer

3. The 2019 WHO classification of tumours of the digestive system

4. Differences in Survival by Histologic Type of Pancreatic Cancer

5. Precursors to Pancreatic Cancer

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer;Signal Transduction and Targeted Therapy;2024-08-21

2. Plasma-Derived Extracellular Vesicles and Non-Extracellular Vesicle Components from APCMin/+ Mice Promote Pro-Tumorigenic Activities and Activate Human Colonic Fibroblasts via the NF-κB Signaling Pathway;Cells;2024-07-15

3. CXCL3: A key player in tumor microenvironment and inflammatory diseases;Life Sciences;2024-07

4. Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response;Clinical and Experimental Medicine;2024-06-12

5. Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies;Frontiers in Oncology;2024-03-25